JAMIE SORENSON: Open Payments
NPI 1457619603 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,231 in 53 payments from 16 companies in 2025. Trend: 2023 $1,820 · 2024 $1,286 · 2025 $1,231
Food & beverage: $1,231
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $220 |
| Almatica Pharma LLC | 6 | $127 |
| Axsome Therapeutics, Inc. | 5 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Neurocrine BioSciences, Inc. | 3 | $91 |
| Alkermes, Inc. | 5 | $83 |
| ABBVIE INC. | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 2 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
Products named: TRINTELLIX, REXULTI, LOREEV XR, COBENFY, INGREZZA, Auvelity, VRAYLAR, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
